US OptionsDetailed Quotes
CHRS241220P1500
- 0.05
- 0.000.00%
15min DelayTrading Dec 19 12:48 ET
0.05High0.05Low
0.05Open0.05Pre Close5 Volume250 Open Interest1.50Strike Price25.00Turnover121.32%IV1.96%PremiumDec 20, 2024Expiry Date0.02Intrinsic Value100Multiplier1DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.5667Delta4.0160Gamma29.59Leverage Ratio-0.0262Theta0.0000Rho-16.77Eff Leverage0.0003Vega
Coherus BioSciences Stock Discussion
Sign in to post a comment
Note: The presence of 30 stock picks reflects the reality that not all stocks respond to their press releases immediately. For instance, today’s market activity saw certain high-performing stocks overshadow promising PRs, suggesting that it may take a day, several days, or even a week for the market to fully digest and react. I encourage you to save the watchlist I p...
34
7
6
$Coherus BioSciences (CHRS.US)$ sucks, not looking good anymore
1
$Coherus BioSciences (CHRS.US)$ bullish finally
2
$Coherus BioSciences (CHRS.US)$ once the shorters got squeeze, easily $4. All in now before its too late.
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Coherus BioSciences (CHRS.US)$
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
7 minutes ago, 4:00 AM PST
Via GlobeNewswire
CHRS
Share
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor -
- Proceeds to fund development of key combination programs with LOQTORZI, including casdozokitug, a first-in-class, cli...
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
7 minutes ago, 4:00 AM PST
Via GlobeNewswire
CHRS
Share
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor -
- Proceeds to fund development of key combination programs with LOQTORZI, including casdozokitug, a first-in-class, cli...
1
No comment yet
Lnova : they sold their shares?![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Trytosaveabit OP Lnova : That I’m not positive of? I know it says D but the code F states that they were taken using money removed directly from his pay for tax liability So since they have good news coming possibly. I would leave each to make up their minds on it! Hehehe. Hope that makes sense? Hehehe
Trytosaveabit OP Lnova : Also if they are expecting the data to be not so good? Maybe that’s why he said just use some of my shares? Hehehe
Lnova Trytosaveabit OP : Oh I see. Thank you. I hadn’t seen this exact thing on a form before. I appreciate you explaining it to me.
Trytosaveabit OP Lnova : You’re welcome! Yes it can be very confusing at times! Hehehe